CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2023	Sep. 25, 2022
Cash flows from operating activities
Net income	$ 122,510	$ 103,119
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	64,173	61,150
Amortization of right of use asset	7,184	7,465
Stock-based compensation expense	38,716	25,299
Multiemployer pension plan liability adjustment	(2,273)	(7,127)
Impairment charges	15,239	0
Gain on sale of land	0	(34,227)
Change in long-term retirement benefit obligations	(21,339)	(19,100)
Contingent consideration fair value adjustment	2,813	0
Other – net	2,582	273
Changes in operating assets and liabilities, net of business acquisitions:
Accounts receivable – net	53,494	74,869
Other assets	9	(25,575)
Accounts payable, accrued payroll and other liabilities	(59,698)	(106,174)
Unexpired subscriptions	690	5,052
Net cash provided by operating activities	224,100	85,024
Cash flows from investing activities
Purchases of marketable securities	(186,018)	(6,650)
Maturities of marketable securities	100,515	469,863
Business acquisitions, net of cash acquired	0	(515,299)
Sales of investments – net	0	(1,886)
Capital expenditures	(16,539)	(27,809)
Other – net	4,754	2,482
Net cash used in investing activities	(97,288)	(79,299)
Long-term obligations:
Dividends paid	(51,360)	(41,878)
Payment of contingent consideration	(2,586)	(1,724)
Capital shares:
Proceeds from stock option exercises	0	3
Repurchases	(43,591)	(79,803)
Share-based compensation tax withholding	(14,279)	(9,837)
Net cash used in financing activities	(111,816)	(133,239)
Net increase/(decrease) in cash, cash equivalents and restricted cash	14,996	(127,514)
Effect of exchange rate changes on cash	(310)	(3,074)
Cash, cash equivalents and restricted cash at the beginning of the period	235,173	334,306
Cash, cash equivalents and restricted cash at the end of the period	$ 249,859	$ 203,718